Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine with or without oral mucosal esketamine for pediatric preoperative sedation
ChiCTR2400084040Phase 4Not yet recruiting
- Sponsor
- Guangzhou Women and Children’s Medical Center
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and esketamine in preoperative anxiety (2 arms), sponsored by Guangzhou Women and Children’s Medical Center. Primary endpoint: Proportion of children with UMSS greater than or equal to 2 at venipuncture. Planned start May 2024; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on ChiCTR2400084040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084040.